Anne P. Drenth
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
The C-Terminal Kinase Domain-Binding and Suppression Motif Prevents Constitutive Activation of FGFR2.
Journal: Cancer research
Published: September 12, 2024
C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3.
Journal: Cancer research
Published: July 26, 2024
Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.
Journal: Nature
Published: September 01, 2022
CD26-negative and CD26-positive tissue-resident fibroblasts contribute to functionally distinct CAF subpopulations in breast cancer.
Journal: Nature communications
Published: May 18, 2022
A BRCA1 Coiled-Coil Domain Variant Disrupting PALB2 Interaction Promotes the Development of Mammary Tumors and Confers a Targetable Defect in Homologous Recombination Repair.
Journal: Cancer research
Published: May 05, 2021
MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling.
Journal: Nature communications
Published: April 02, 2021
Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.
Journal: Nature
Published: January 19, 2021
Truncated ASPP2 Drives Initiation and Progression of Invasive Lobular Carcinoma via Distinct Mechanisms.
Journal: Cancer research
Published: November 15, 2019
TRPS1 acts as a context-dependent regulator of mammary epithelial cell growth/differentiation and breast cancer development.
Journal: Genes & development
Published: August 02, 2019
Exogenous ERα Expression in the Mammary Epithelium Decreases Over Time and Does Not Contribute to p53-Deficient Mammary Tumor Formation in Mice.
Journal: Journal of mammary gland biology and neoplasia
Published: June 18, 2019
Last Updated: 09/26/2026